Monday, May 4, 2015
- 8:30am-8:45am
-
Plasma Levels of Donor-Derived Cell-Free DNA Increase With Rejection and Often Decrease After Treatment in Organ Transplant Recipients
Plenary Session II • Terrace Ballroom 1, 2, 3
- 8:45am-9:00am
-
Induction With ATG Is Not Associated With Increased Infections After Kidney Transplant Among HIV Positive Patients: Results of a National Study
Plenary Session II • Terrace Ballroom 1, 2, 3
- 9:00am-9:15am
-
Hepatocyte-Related miR-193a-3p Is Over-Expressed in Allograft Biopsy from Liver Tolerant Recipients
Plenary Session II • Terrace Ballroom 1, 2, 3
- 9:15am-9:30am
-
Deceased Donor and Class II Donor Specific Antibody Predict Interface Activity While Increased Age at Time of Biopsy Predicts Fibrosis in Long-Term Pediatric Liver Allografts With Normal Liver Tests: iWITH Clinical Trial
Plenary Session II • Terrace Ballroom 1, 2, 3
- 2:15pm-2:27pm
-
A Common Gene Signature Across Multiple Studies Identifies Biomarkers and Functional Regulation in Tolerance to Renal Allograft
Concurrent Session: Tolerance: Clinical Studies • Room 122-AB
- 2:15pm-2:27pm
-
Aquaporin 4 Blockade Is a Novel Strategy Targeting Ischemia/Reperfusion Injury in Heart Transplantation
- 2:15pm-2:27pm
-
Early Hospital Readmissions After Kidney Transplantation
Concurrent Session: Kidney: Hospitalization/Readmission • Room 118-AB
- 2:15pm-2:27pm
-
Elevated ST2 Levels Are Associated With Increased Risk of Antibody Mediated Rejection in Heart Transplant Recipients
- 2:15pm-2:27pm
-
Epidemiology and Outcomes of Non Tuberculous Mycobacterial (NTM) Infections in Solid Organ Transplant (SOT) Recipients
- 2:15pm-2:27pm
-
Extended Analysis of Tocilizumab (anti-IL-6R) + Intravenous Immunoglobulin (IVIG) as Desensitization (DES) Agents for Reduction of Donor Specific Antibodies (DSA) in Patients Resistant to DES With IVIG + Rituximab
Concurrent Session: Kidney: Desensitization • Terrace I-III
- 1
- 2
- 3
- …
- 48
- Next Page»